TA-CIN/GPI-0100 HPV16 vaccine (Johns Hopkins University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTA-CIN/GPI-0100 HPV16 vaccine (Johns Hopkins University)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University

Inactive CompaniesN/A

Active IndicationsUterine Cervical NeoplasmsPapillomavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A